(Reuters) – Aimmune Therapeutics Inc on Monday warned of a slow launch of its peanut allergy therapy, as its marketing plans take a hit from U.S. authorities’ recommendation of social distancing to contain the spread of the coronavirus. […]
https://www.reuters.com/article/us-health-coronavirus-aimmune/aimmune-sees-coronavirus-slowing-down-marketing-of-peanut-allergy-therapy-idUSKBN2133I6
Repost: Aimmune sees coronavirus slowing down marketing of peanut allergy therapy
Repost: Aimmune sees coronavirus slowing down marketing of peanut allergy therapy
March 17, 2020